The nation of Zimbabwe has rejected a substantial American healthcare agreement worth 367 million US dollars (£272m) spanning five years because of the United States' request for sensitive data.
This rejection became public after a government memo from December was disclosed, indicating that Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
An official spokesperson later stated that the US was requesting biological samples for research and commercial gain while was unwilling to share the benefits from future medical innovations.
"We will now turn to the challenging and unfortunate task of winding down our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated more than $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has called for continued dialogue to find a agreement agreeable to both sides so the nation's critical HIV programme can continue.
Broader Background
This development follows a similar situation in Kenya, where a court blocked a related deal with the US following concerns were filed about the safety of citizens' health data.
After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking direct bilateral agreements to boost transparency and accountability.
According to reports, Sixteen African countries have to date agreed to similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership could have provided extraordinary benefits for the people of Zimbabwe, especially the 1.2 million currently on antiretroviral therapy through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the proposed deal was "asymmetrical".
"Our nation was requested to share its genetic material and health information indefinitely, with no equivalent guarantee of access to any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.
"Put simply, our country would provide the basic resources for medical research with no certainty that the end products would be available to our people should a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining systems already set up through the global organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future global health emergencies.
"This framework is intended to guarantee that when a nation contributes its information, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the resources to create them."
Zimbabwe's reservations over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We welcome continued discussions with our US partners on how future collaboration might be designed in a way that honours the independence and dignity of both nations."
Health Experts Reaction
A leading public health body stated it recognised the government's concerns, but recommended that talks should continue considering a large portion of the nation's HIV programmes were funded by external financing.
"In cases where technical issues exist, including those relating to data governance or agreement terms, these can frequently be addressed via detailed discussion and mutually agreed protections," it commented.
This impasse underscores the continuing tensions between accepting vital foreign assistance and protecting a country's data in an increasingly interconnected world.